advertisement
Inoue T 8
Showing records 1 to 8 | Display all abstracts from Inoue T72728 Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot Study
Matsumura R
Clinical Drug Investigation 2017; 37: 535-539
72953 Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA)
Futakuchi A
Investigative Ophthalmology and Visual Science 2017; 58: 2421-2429
72728 Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot Study
Inoue T
Clinical Drug Investigation 2017; 37: 535-539
72953 Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA)
Inoue T; Fujimoto T
Investigative Ophthalmology and Visual Science 2017; 58: 2421-2429
72728 Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot Study
Matsumura A
Clinical Drug Investigation 2017; 37: 535-539
72953 Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA)
Kuroda U
Investigative Ophthalmology and Visual Science 2017; 58: 2421-2429
72728 Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot Study
Tanihara H
Clinical Drug Investigation 2017; 37: 535-539
72953 Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA)
Inoue-Mochita M; Takahashi E; Ohira S; Tanihara H
Investigative Ophthalmology and Visual Science 2017; 58: 2421-2429
